Literature DB >> 27481272

The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease.

Christian Dejaco1, Christina Duftner2, Frank Buttgereit3, Eric L Matteson4, Bhaskar Dasgupta5.   

Abstract

GCA and PMR are conditions of older persons that frequently overlap. The traditional concept of GCA has focused on cranial symptoms such as headache and visual disturbance, but extra-cranial manifestations such as constitutional symptoms, polymyalgia and limb claudication have also long been recognized. These symptoms may coincide with cranial GCA, occur as an independent clinical subset [large-vessel (LV) GCA] or overlap with PMR. Imaging studies have demonstrated that up to one-third of patients with PMR have subclinical LV inflammation at disease outset. The implication of this finding for PMR management is unclear. Pathophysiological studies have emphasized the pivotal role of dendritic cells (DCs) and T cells in the pathogenesis of GCA, and the activation of certain pattern recognition receptors on DCs may determine the clinical subset of GCA. In patients with only PMR clinically, it is conceivable that transmural arterial inflammation has either not yet started or is prevented by unexplored regulatory pathways. This concept is supported by vasculitis of peri-adventitial small-vessels and activated DCs in the adventitia of temporal arteries, in the absence of media-infiltrating T cells. This review examines the clinical and pathophysiological spectrum of GCA and its subsets with PMR, the role of newer imaging techniques for GCA diagnosis and the management of these diseases.
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  biological therapies; diagnostic imaging; giant cell arteritis; immunosuppressants; polymyalgia rheumatica; vasculitis

Mesh:

Substances:

Year:  2017        PMID: 27481272     DOI: 10.1093/rheumatology/kew273

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  46 in total

Review 1.  Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management.

Authors:  Alvise Berti; Roberto Caporali; Carlomaurizio Montecucco; Giuseppe Paolazzi; Sara Monti
Journal:  Drugs Aging       Date:  2019-01       Impact factor: 3.923

Review 2.  Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities.

Authors:  Christian Dejaco; Elisabeth Brouwer; Justin C Mason; Frank Buttgereit; Eric L Matteson; Bhaskar Dasgupta
Journal:  Nat Rev Rheumatol       Date:  2017-09-14       Impact factor: 20.543

Review 3.  EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice summary.

Authors:  Mohammad Bardi; Andreas P Diamantopoulos
Journal:  Radiol Med       Date:  2019-06-28       Impact factor: 3.469

4.  Clinical and technical determinants of positive temporal artery biopsy: a retrospective cohort study.

Authors:  Fatima Alnaimat; Ahmad T Mansour; Hamza Alduraidi; Soud Al-Qasem; Mohammad Hindi; Tala Rawashdeh; Eman Hassan; Sahar Almustafa; Refat Hanbali; Osama Ababneh
Journal:  Rheumatol Int       Date:  2021-10-18       Impact factor: 2.631

5.  Incidence, survival, and diagnostic trends in GCA across seven decades in a North American population-based cohort.

Authors:  Thomas D Garvey; Matthew J Koster; Cynthia S Crowson; Kenneth J Warrington
Journal:  Semin Arthritis Rheum       Date:  2021-09-27       Impact factor: 5.532

6.  The microvascular niche instructs T cells in large vessel vasculitis via the VEGF-Jagged1-Notch pathway.

Authors:  Zhenke Wen; Yi Shen; Gerald Berry; Farhad Shahram; Yinyin Li; Ryu Watanabe; Yaping Joyce Liao; Jörg J Goronzy; Cornelia M Weyand
Journal:  Sci Transl Med       Date:  2017-07-19       Impact factor: 17.956

Review 7.  Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica.

Authors:  Dario Camellino; Eric L Matteson; Frank Buttgereit; Christian Dejaco
Journal:  Nat Rev Rheumatol       Date:  2020-08-05       Impact factor: 20.543

8.  Acute Lateral Medullary Infarct due to Giant Cell Arteritis: A Case Study.

Authors:  Joseph M Dardick; Charles C Esenwa; Richard L Zampolin; Berrin Ustun; Bibi Ayesha; Kathryn F Kirchoff-Torres; Ava L Liberman
Journal:  Stroke       Date:  2019-09-09       Impact factor: 7.914

Review 9.  A new era for giant cell arteritis.

Authors:  H S Lyons; V Quick; A J Sinclair; S Nagaraju; S P Mollan
Journal:  Eye (Lond)       Date:  2019-10-03       Impact factor: 3.775

10.  Boundaries of a systemic disease: a protean presentation of giant cell arteritis.

Authors:  António Mesquita; Lara Camara; Catarina Patrício; Vítor Brotas
Journal:  BMJ Case Rep       Date:  2020-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.